Literature DB >> 23279345

Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V.

Hye Jin Lee1, Jin Park, Khriezanou Nakhro, Jin Mo Park, Yoon-Mi Hur, Byung-Ok Choi, Ki Wha Chung.   

Abstract

Glycyl-tRNA synthetase (GARS), which encodes the enzyme responsible for charging tRNA(Gly) with glycine in both the cytoplasm and mitochondria, is implicated to Charcot-Marie-Tooth disease 2D (CMT2D) and distal hereditary motor neuropathy type V (dHMN-V). We performed whole exome sequencing (WES) to identify the genetic defects in the two dHMN families. WES revealed several decades of non-synonymous variants in the CMT and aminoacyl-tRNA synthetase genes. The subsequent capillary sequencing for family members and controls revealed two novel causative mutations, c.598G>A (D200N) and c.794C>T (S265F), in the GARS gene in each dHMN family. Both mutations were cosegregated with affected individuals in each family, and were not found in the 200 controls. The mutation sites were well conserved between the different species and in silico analysis predicted that both mutations may affect protein function. Therefore, we believe that these two novel GARS mutations are the underlying causes of the dHMN phenotype.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279345     DOI: 10.1111/j.1529-8027.2012.00442.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  27 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models.

Authors:  Kathryn H Morelli; Laurie B Griffin; Nettie K Pyne; Lindsay M Wallace; Allison M Fowler; Stephanie N Oprescu; Ryuichi Takase; Na Wei; Rebecca Meyer-Schuman; Dattatreya Mellacheruvu; Jacob O Kitzman; Samuel G Kocen; Timothy J Hines; Emily L Spaulding; James R Lupski; Alexey Nesvizhskii; Pedro Mancias; Ian J Butler; Xiang-Lei Yang; Ya-Ming Hou; Anthony Antonellis; Scott Q Harper; Robert W Burgess
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 3.  Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.

Authors:  Stephanie N Oprescu; Laurie B Griffin; Asim A Beg; Anthony Antonellis
Journal:  Methods       Date:  2016-11-20       Impact factor: 3.608

4.  CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.

Authors:  Biljana Ermanoska; William W Motley; Ricardo Leitão-Gonçalves; Bob Asselbergh; LaTasha H Lee; Peter De Rijk; Kristel Sleegers; Tinne Ooms; Tanja A Godenschwege; Vincent Timmerman; Kenneth H Fischbeck; Albena Jordanova
Journal:  Neurobiol Dis       Date:  2014-05-05       Impact factor: 5.996

5.  Elaborate uORF/IRES features control expression and localization of human glycyl-tRNA synthetase.

Authors:  Jana Alexandrova; Caroline Paulus; Joëlle Rudinger-Thirion; Fabrice Jossinet; Magali Frugier
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

6.  Large Conformational Changes of Insertion 3 in Human Glycyl-tRNA Synthetase (hGlyRS) during Catalysis.

Authors:  Xiangyu Deng; Xiangjing Qin; Lei Chen; Qian Jia; Yonghui Zhang; Zhiyong Zhang; Dongsheng Lei; Gang Ren; Zhihong Zhou; Zhong Wang; Qing Li; Wei Xie
Journal:  J Biol Chem       Date:  2016-01-21       Impact factor: 5.157

7.  Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.

Authors:  Laurie B Griffin; Reiko Sakaguchi; David McGuigan; Michael A Gonzalez; Charles Searby; Stephan Züchner; Ya-Ming Hou; Anthony Antonellis
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

8.  Cocrystal structures of glycyl-tRNA synthetase in complex with tRNA suggest multiple conformational states in glycylation.

Authors:  Xiangjing Qin; Zhitai Hao; Qingnan Tian; Zhemin Zhang; Chun Zhou; Wei Xie
Journal:  J Biol Chem       Date:  2014-06-04       Impact factor: 5.157

Review 9.  Next-generation sequencing for mitochondrial disorders.

Authors:  C J Carroll; V Brilhante; A Suomalainen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

10.  A recurrent GARS mutation causes distal hereditary motor neuropathy.

Authors:  Diana C Lee; Rebecca Meyer-Schuman; Chelsea Bacon; Michael E Shy; Anthony Antonellis; Steven S Scherer
Journal:  J Peripher Nerv Syst       Date:  2019-11-22       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.